Related Experiment Video
Updated: Aug 18, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
Total synthesis of macroviracin D (BA-2836-4)
Jacek Mlynarski1, Juliana Ruiz-Caro, Alois Fürstner
1Max-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.
Abstract:
The first total synthesis of the complex glycolipid macroviracin D (BA-2836-4) (1) is described. This antivirally active metabolite isolated from the mycelium extracts of Streptomyces sp. BA-2836 incorporates a unique 46-membered macrodilactone motif decorated with glycosylated fatty acid appendices. Compound 1 consists of three identical subunits which are closely related to one of the segments found in cycloviracin B(1) (2), another antiviral glycoconjugate previously synthesized in our laboratory. Key steps of the synthesis route to 1 involve the stereoselective, ligand-controlled addition of the functionalized diorganozinc derivative 9 to aldehydes 8 a, b, a series of beta-selective glycosidation reactions using appropriately protected trichloroacetimidate donors, and three esterifications via the Yamaguchi method; one of them is performed intramolecularly to forge the macrocyclic lactone ring of the target in 89 % isolated yield. This total synthesis also firmly establishes the absolute configuration of the subunits of compound 1 as 3R,17S,23R.
Related Concept Videos
Pharmaceutical Equivalents
Antimicrobial Effectiveness
Subviral Agents
Antiviral Nucleoside Inhibitors
Antifungal Agents

